LumiQ^TM

All-in-one Immunofluorescence (IFA) solution

Turnkey solution for autoimmune disease

The combination of MosaiQ^® and LumiQ platforms provides a unique, automated, seamlessly integrated solution to cover your needs for screening and identification of autoantibodies for a wide range of diseases.

The LumiQ system is designed to provide workflow efficiency from patient sample in, to result out.

We aim to empower better informed, personalized clinical decisions, improving quality of care and reducing the burden of chronic illnesses for patients in need.

Indirect immunofluorescence remains the standard method for testing of various antibodies. The detection and measurement of autoantibodies have significantly evolved with automation, offering laboratories more enhanced options.

Offering a new level of performance from a benchtop immunofluorescence solution, the LumiQ platform will be able to perform two batches simultaneously, automated from patient sample to result.

The LumiQ system is designed to help reduce time-to-diagnosis for patients with autoimmune disease.

Optimized Workflow

Patients sample in, result out in one single step
True walkaway time

Standardization

Minimizes impact of subjectivity and avoids human error
Provides positive and negative pre-classification

Actionable Insights

Image capture and data storage helps patient history management
Provides estimate endpoint titer

Designed to Provide Fast, Actionable Insights with an Intuitive User Experience

Key Features

Up to 216 samples in one single run.
12 different assays within the same run.
Up to 27 slides from different tests in one run.
Supports run of two simultaneous batches.
Positive/negative pre-classification.
Estimated endpoint titer.
Suggested pattern recognition based on sophisticated algorithm.

Discover how the LumiQ system can help
simplify your workflow

Learn more about our solutions:

MosaiQ AiPlex CD AiPlex CTD AiPlex CTDplus

© AliveDx Suisse SA, 2024. AliveDx, the AliveDx logo, AiPlex, LumiQ and MosaiQ are trademarks or registered trademarks of AliveDx group companies in various jurisdictions. Menus and capabilities are subject to change. Subject to regulatory authorization, not all methods may be available in all territories.